Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
Zhen Zhang, Jianjun Li, Yang Ou, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Steps in metastasis: an updated review
Jamal Majidpoor, Keywan Mortezaee
Medical Oncology (2021) Vol. 38, Iss. 1
Closed Access | Times Cited: 211
The role of ubiquitination and deubiquitination in tumor invasion and metastasis
Shuangze Han, Ruike Wang, Yangnan Zhang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 6, pp. 2292-2303
Open Access | Times Cited: 110
Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer
Huimin Jiang, Huimin Wei, Hang Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 97
A review on the role of cyclin dependent kinases in cancers
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 79
EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?
Azamat Akhmetkaliyev, Noura Alibrahim, Darya Shafiee, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 71
The ubiquitin–proteasome system in breast cancer
Dianwen Han, Lijuan Wang, Shan Jiang, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 599-621
Closed Access | Times Cited: 43
Targeting USP8 Inhibits O‐GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT
Jianing Tang, Guo Long, Kuan Hu, et al.
Advanced Science (2023) Vol. 10, Iss. 33
Open Access | Times Cited: 43
Recent Advances in Small Molecule Inhibitors of Deubiquitinating Enzymes
Pengwei Liu, Zhengyang Chen, Yiting Guo, et al.
European Journal of Medicinal Chemistry (2025), pp. 117324-117324
Closed Access | Times Cited: 3
MIR497HG‐Derived miR‐195 and miR‐497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer
Yao Tian, Zhaohui Chen, Peng Wu, et al.
Advanced Science (2023) Vol. 10, Iss. 12
Open Access | Times Cited: 40
HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma
Zhipeng Li, Huaxin Zhou, Zhijia Xia, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Protein degradation: expanding the toolbox to restrain cancer drug resistance
Hui Ming, Bowen Li, Jingwen Jiang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 30
Organ Tropism in Solid Tumor Metastasis: An Updated Review
Keywan Mortezaee
Future Oncology (2021) Vol. 17, Iss. 15, pp. 1943-1961
Closed Access | Times Cited: 46
Engineered mesenchymal stem cell-derived exosomes with high CXCR4 levels for targeted siRNA gene therapy against cancer
Shuyue Xu, Bin Liu, Junyi Fan, et al.
Nanoscale (2022) Vol. 14, Iss. 11, pp. 4098-4113
Closed Access | Times Cited: 37
USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics
Yuanjie Liu, Shuhong Zeng, Wei Zhang, et al.
Pharmacological Research (2023) Vol. 188, pp. 106644-106644
Open Access | Times Cited: 22
USP51/PD‐L1/ITGB1‐deployed juxtacrine interaction plays a cell‐intrinsic role in promoting chemoresistant phenotypes in non‐small cell lung cancer
Jianjun Li, Xuechun Xiao, Yang Ou, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 765-787
Open Access | Times Cited: 20
PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression
Zi-Mei Peng, Xiaojian Han, Tao Wang, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 6
Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer
Shirui Wang, Dan Luo, Chunlan Pu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 248, pp. 115082-115082
Open Access | Times Cited: 13
SLC7A11 protects luminal A breast cancer cells against ferroptosis induced by CDK4/6 inhibitors
Yingshu Cui, Yi Li, Yuanyuan Xu, et al.
Redox Biology (2024) Vol. 76, pp. 103304-103304
Open Access | Times Cited: 5
Long Non-Coding RNA PCED1B-AS1 Promotes the Progression of Clear Cell Renal Cell Carcinoma Through miR-484/ZEB1 Axis
Jianhua Qin, Tingting Zhu, Weihua Wu, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 393-402
Open Access | Times Cited: 29
Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer
Misha Mao, Yongxia Chen, Jingjing Yang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005668-e005668
Open Access | Times Cited: 21
Post-Translational Modification of ZEB Family Members in Cancer Progression
Mi Kyung Park, Ho Lee, Chang Hoon Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15127-15127
Open Access | Times Cited: 20
The cyclin‐dependent kinase inhibitor AT7519 is a human RORγt agonist
Kaja Karaś, Joanna Pastwińska, Anna Sałkowska, et al.
Immunology and Cell Biology (2025)
Closed Access
SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis
Chen Tang, Shengmeng Peng, Yongming Chen, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
TRIM44 facilitates aggressive behaviors in multiple myeloma through promoting ZEB1 deubiquitination
Hui Qi, Jing Wang, Lixia Cao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
USP51/GRP78/ABCB1 axis confers chemoresistance through decreasing doxorubicin accumulation in triple-negative breast cancer cells
Yang Ou, Kun Zhang, Qiuying Shuai, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Page 1 - Next Page

Scroll to top